Latest filing published 31 Jul 2026 for Angiodynamics INC, €300k.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Warren Nighan Jr. discloses dealings in 2 companies, chiefly Angiodynamics Inc and Haemonetics Corp. The record holds 34 filings, for trades running from 26 January 2011 to 30 July 2026.
Market trades split into 2 purchases (€4,817) and 6 sales (€795k). Taken together, the sales exceed the purchases by €790k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 19 share grants and 5 option exercises. 2026 to date brings no purchases and 1 sale.
Most recently, on 31 July 2026, the filings show an open-market sale worth €300k in Angiodynamics Inc. The most recent open-market purchase was published on 10 October 2024, 743 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations